Shirley Yi Fen Hii - Infectious Diseases

Author Information

Shirley Yi Fen Hii is affiliated with the Bacteriology Unit, Infectious Diseases Research Centre at the Institute for Medical Research, part of the National Institutes of Health, Ministry of Health Malaysia. Her research is conducted at the organization located in Shah Alam, Selangor, Malaysia. Her work primarily focuses on infectious diseases, with a particular interest in bacteriology and related fields.

Research Contributions

Shirley Yi Fen Hii has made significant contributions to the field of infectious diseases with a focus on bacterial infections. Her research includes antibiotic susceptibility and genomic characterization of clinical isolates of Burkholderia pseudomallei in Thailand, molecular and SNP-based phylogenetic analyses of Corynebacterium diphtheriae in Malaysia, and the serodiagnosis of melioidosis. She has also worked on genome sequencing of Salmonella enterica and Corynebacterium diphtheriae isolates. Her studies provide valuable insights into the molecular epidemiology and diagnostic approaches for bacterial pathogens in the region.

Aliases

Shirley Yi Fen Hii is also known by the aliases S F F Hii and S. F. F. Hii. These variations are used interchangeably in her publications and professional affiliations.

Publication and Citation Metrics

Metric	Value
Total Papers	7
Citation Count	37
h-index	4

Publications:

Antibiotic Susceptibility of Clinical Burkholderia pseudomallei Isolates in Northeast Thailand from 2015 to 2018 and the Genomic Characterization of β-Lactam-Resistant Isolates

DOI: 10.1128/AAC.02230-20

Year: 2021

Molecular characterization of Corynebacterium diphtheriae isolates in Malaysia between 1981 and 2016.

DOI: 10.1099/jmm.0.000881

Year: 2019

A SNP-based phylogenetic analysis of Corynebacterium diphtheriae in Malaysia

DOI: 10.1186/s13104-018-3868-6

Year: 2018

Comparison of in-house IgM and IgG ELISAs for the serodiagnosis of melioidosis in Malaysia

DOI: 10.1099/jmm.0.000611

Year: 2017

Draft Genome Sequence of Salmonella enterica Serovar Typhi IMR_TP298/15, a Strain with Intermediate Susceptibility to Ciprofloxacin, Isolated from a Typhoid Outbreak

DOI: 10.1128/genomeA.01740-16

Year: 2017

First Draft Genome Sequences of Malaysian Clinical Isolates of Corynebacterium diphtheriae

DOI: 10.1128/genomeA.01670-16

Year: 2017

Melioidosis: Overview of seropositivity in Malaysia.

DOI:

Year: 2016

What Treatments are Available for Bacterial Infections?

How Does Proteomics Help in Understanding Infectious Diseases?

What are the Benefits of Gene Therapy and Immunotherapy?

What Are the Challenges in Implementing AI?

How Can We Support the Global Fund?

How is Gene Therapy Applied in Infectious Diseases?

What is a Pathogen?

How Can Bacterial Infections Be Prevented?

What Challenges Exist in Measles Control?

What is Aedes Albopictus?

Partnered Content Networks

Relevant Topics